Abstract:Background: Iron metabolism may be involved in the pathogenesis of the non-alcoholic fatty liver disease (NAFLD). The relationship between iron metabolism and NAFLD has not been clearly established. This study aimed to clarify the relationship between biomarkers of iron metabolism and NAFLD. Methods: Based on the National Health and Nutrition Examination Survey (NHANES), restricted cubic spline models and multivariable logistic regression were used to examine the association between iron metabolism [serum iron (SI), serum ferritin (SF), transferrin saturation (TSAT), and soluble transferrin receptor (sTfR)] and the risk for NAFLD. In addition, stratified subgroup analysis was performed for the association between TSAT and NAFLD. Moreover, serum TSAT levels were determined in male mice with NAFLD. The expression of hepcidin and ferroportin, vital regulators of iron metabolism, were analyzed in the livers of mice by quantitative real-time PCR (qRT-PCR) and patients with NAFLD by microarray collected from the GEO data repository. Results: Patients with NAFLD showed decreased SI, SF, and TSAT levels and increased STfR levels based on the NHANES. After adjusting for confounding factors, TSAT was significantly negatively correlated with NAFLD. Of note, the relationship between TSAT and NAFLD differed in the four subgroups of age, sex, race, and BMI (P for interaction < 0.05). Consistently, mice with NAFLD exhibited decreased serum TSAT levels. Decreased hepcidin and increased ferroportin gene expression were observed in the livers of patients and mice with NAFLD. Conclusion: Serum TSAT levels and hepatic hepcidin expression were decreased in both patients and mice with NAFLD. Among multiple biomarkers of iron metabolism, lower TSAT levels were significantly associated with a higher risk of NAFLD in the U.S. general population. These findings might provide new ideas for the prediction, diagnosis, and mechanistic exploration of NAFLD.

Long‐Term High‐Fat Diet Decreases Hepatic Iron Storage Associated with Suppressing TFR2 and ZIP14 Expression in Rats

Effects of Dietary Zinc on Hepatic Fatty Acid Metabolism of Rats

Effects of Zinc on Hepatic Antioxidant Systems and the Mrna Expression Levels Assayed by Cdna Microarrays in Rats

Iron Overload Protects from Obesity by Ferroptosis

High-iron Diet Damages Brown Adipose Tissue Mitochondria and Exacerbates Metabolic Hazards of a High-Fat Diet

Impaired Ferritinophagy Flux Induced by High Fat Diet Mediates Hepatic Insulin Resistance Via Endoplasmic Reticulum Stress.

A Low Iron Diet Protects from Steatohepatitis in a Mouse Model

Dietary Iron Modulates Glucose and Lipid Homeostasis in Diabetic Mice

Regulation of a High-Iron Diet on Lipid Metabolism and Gut Microbiota in Mice

High Iron Exposure from the Fetal Stage to Adulthood in Mice Alters Lipid Metabolism

Diet-induced obesity leads to decreased hepatic iron storage in mice

Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease

Repeated Restraint Stress Enhances Hepatic TFR2 Expression and Induces Hepatic Iron Accumulation in Rats

Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017-2018) and a controlled animal study

Iron supplementation regulates the progression of high fat diet induced obesity and hepatic steatosis via mitochondrial signaling pathways

Iron Increases Lipid Deposition Via Oxidative Stress-Mediated Mitochondrial Dysfunction and the HIF1α-PPARγ Pathway.

Iron Overload Coordinately Promotes Ferritin Expression and Fat Accumulation in Caenorhabditis Elegans.

Betaine Alleviates High-Fat Diet-Induced Disruptionof Hepatic Lipid and Iron Homeostasis in Mice.

Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis

Effects of High Dietary Iron on the Lipid Metabolism in the Liver and Adipose Tissue of Male Broiler Chickens

Suppressed farnesoid X receptor by iron overload in mice and humans potentiates iron-induced hepatotoxicity